InvestorsHub Logo
Followers 275
Posts 32725
Boards Moderated 0
Alias Born 11/14/2013

Re: Evaluate post# 54978

Wednesday, 02/24/2016 2:28:35 PM

Wednesday, February 24, 2016 2:28:35 PM

Post# of 703184
Looks like there are other companies using anti-CXCR4 therapies in clinical trials. Search clinicaltrialls.gov.

The important thing is that NWBO has a patent, so apparently its CXCR4 antibody is at least available to use in combination with other therapies.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News